Articles from Elevance Health, Inc.

Elevance Health, Inc. (NYSEELV) reported fourth quarter and full year 2024 results.

Elevance Health (NYSEELV) will release fourth quarter and full year 2024 financial results on January 23, 2025, at 6:00 a.m. Eastern Standard Time (“EST”). Management will review these results and its outlook during a conference call at 8:30 a.m. EST that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:

Elevance Health (NYSEELV) announced today that senior management is scheduled to present at the UBS Global Healthcare Conference in Rancho Palos Verdes, California on November 12, at 7:15 a.m. Pacific Standard Time (PST) / 10:15 a.m. Eastern Standard Time (EST). All interested parties are invited to listen to a live webcast of the presentation by visiting www.elevancehealth.com and selecting the “Investors” link. You may also access the link here.

Elevance Health (NYSEELV) announced today the appointment of Nathan Rich as Vice President, Investor Relations, effective November 11, 2024. In this role, Mr. Rich will lead Elevance Health's investor relations efforts, providing strategic leadership to support the company’s growth initiatives and strengthen relationships within the investment community. He will also serve as a member of the company’s executive leadership team and will report directly to Mark Kaye, Executive Vice President and Chief Financial Officer. Mr. Rich succeeds Stephen Tanal, who now serves as Chief Financial Officer for Elevance Health’s Government Health Benefits business.

Elevance Health, Inc. (NYSEELV) reported third quarter 2024 results.

Elevance Health (NYSEELV) will release third quarter 2024 financial results on October 17, 2024, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:

Elevance Health and its philanthropic arm, Elevance Health Foundation, are committed to strengthening the health of communities across the U.S. through community resiliency and disaster response efforts related to Hurricane Helene.

The Whole Health Index (WHI), created by Elevance Health, Inc. (NYSEELV) physicians, data scientists, and researchers, is a first-of-its-kind assessment of health. Using a scale of 0 to 100, the WHI can evaluate a person or group’s relative health over time and assess the physical, behavioral, and social factors that influence it.

Irvington Preparatory Academy today unveiled their first ever weight room and fitness space, provided by Elevance Health in partnership with the Impact Fitness Foundation (IFF), a national nonprofit that provides fitness resources to schools. The facility upgrade marks the third Indianapolis high school to receive a new fitness space in celebration of the Elevance Health Women’s Fort Myers Tip-Off, a pre-season collegiate basketball tournament that takes place in November.

Elevance Health, Inc. (NYSEELV) reported second quarter 2024 results.

Elevance Health released its annual Impact Report, highlighting its continued evolution from a traditional health insurance benefits company to a diversified healthcare services organization.

Elevance Health (NYSEELV) will release second quarter 2024 financial results on July 17, 2024, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:

Elevance Health (NYSEELV) announced today that senior management is scheduled to present at Goldman Sachs 45th Annual Global Healthcare Conference in Miami Beach, Florida on June 12 at 1:20 p.m. Eastern Daylight Time (EDT). All interested parties are invited to listen to a live webcast of the presentation by visiting www.elevancehealth.com and selecting the “Investors” link. You may also access the link here.

Elevance Health (NYSEELV) announced today that senior management is scheduled to present at Bernstein's 40th Annual Strategic Decisions Conference in New York City, on May 31 at 9:00 a.m. Eastern Daylight Time (EDT). All interested parties are invited to listen to a live webcast of the presentation by visiting www.elevancehealth.com and selecting the “Investors” link. You may also access the link here.

Elevance Health, Inc. (NYSEELV) reported first quarter 2024 results.

Elevance Health, Inc. (NYSEELV) and Clayton, Dubilier & Rice (CD&R) announced an agreement to form a strategic partnership to accelerate innovation in primary care delivery, enhance the healthcare experience, and improve health outcomes. This effort, which will operate across multiple regions of the United States, will bring together certain care delivery and enablement assets of Elevance Health’s Carelon Health and CD&R portfolio companies, apree health and Millennium Physician Group (MPG).

Elevance Health (NYSEELV) will release first quarter 2024 financial results on April 18, 2024, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:

Elevance Health (NYSEELV) today announced the closing of its acquisition of Paragon Healthcare, Inc., a company specializing in life-saving and life-giving infusible and injectable therapies.

Elevance Health (NYSEELV) announced today that senior management is scheduled to present at the Cowen 44th Annual Health Care Conference in Boston on March 5, at 2:50 p.m. Eastern Standard Time (EST). All interested parties are invited to listen to a live webcast of the presentation by visiting www.elevancehealth.com and selecting the “Investors” link. You may also access the webcast here.

Elevance Health (NYSEELV) announced today that senior management is scheduled to present at Barclays 26th Annual Global Healthcare Conference in Miami, on March 14 at 9:30 a.m. Eastern Daylight Time (EDT). All interested parties are invited to listen to a live webcast of the presentation by visiting www.elevancehealth.com and selecting the “Investors” link. You may also access the link here.

Today JUST Capital along with CNBC released its annual JUST 100 list as part of its 2024 Rankings of America’s Most JUST Companies. Elevance Health (NYSEELV) ranked #8 overall and was recognized for the 6th consecutive year for its commitment to serving its workers, customers, communities, the environment, and shareholders.

Elevance Health, Inc. (NYSEELV) reported fourth quarter and full year 2023 results.

Elevance Health announced at the Consumer Electronics Show 2024 that it will launch a first-of-its-kind program that will offer high-quality smartphones with unlimited data, talk, and texting service at no cost to eligible individuals enrolled in some of its affiliated Medicaid health plans. These devices will be preloaded with a customized experience and give individuals access to digital and virtual healthcare tools that they might otherwise not have had.

Elevance Health (NYSEELV) today announced that it has entered into an agreement to acquire Paragon Healthcare, Inc., a company specializing in life-saving and life-giving infusible and injectable therapies.

Elevance Health, Inc. (NYSEELV) recently received the new Health Equity Accreditation Plus for 21 of its affiliated Medicaid plans from the National Committee for Quality Assurance (NCQA), a recognition that the company leads the industry in developing solutions to ensure access to high quality, equitable healthcare.

As part of its ongoing commitment to health equity and medical workforce development, Elevance Health is investing $1.42 million to support the National Inclusive Curriculum for Health Education—Medical (NICHE – Medical) community-engaged approach to Intellectual and Development Disability (IDD) curriculum by medical schools across the country.

Elevance Health, Inc. (NYSEELV) reported third quarter 2023 results reflecting strong financial performance across the enterprise.

Elevance Health (NYSEELV) will release third quarter 2023 financial results on October 18, 2023 at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:

Elevance Health (NYSEELV) announced today that its affiliated health plans will offer simplified and flexible Medicare Advantage plans with customizable supplemental benefits to respond to the preferences of nearly 38.5 million Medicare-eligible consumers in the company’s service area, which includes 22 states and Puerto Rico.

As part of their ongoing commitment to equity and providing support for women and women’s health, Elevance Health has partnered with national nonprofit Impact Fitness Foundation to create a fitness and movement space for K-12 public school network Victory College Prep (VCP), in celebration of the Elevance Health Women’s Fort Myers Tipoff, a pre-season women’s collegiate basketball tournament.

Elevance Health (NYSEELV) announced today that John Gallina will retire from his role as executive vice president and CFO later this year. Mark Kaye has been named executive vice president and CFO and will serve as a member of the company’s executive leadership team, reporting directly to Gail K. Boudreaux, President and CEO. Kaye will serve as CFO Designate from September 6 to November 1, 2023, when he will assume full responsibility for the role. Gallina will remain with Elevance Health serving as Special Advisor to the CEO following his retirement as CFO to ensure a seamless transition.

Amerigroup, a subsidiary of Elevance Health serving Medicaid and Medicare enrollees, will begin rebranding as Wellpoint in January 2024, to reflect the company’s evolution to support whole health.

Elevance Health, Inc. (NYSEELV) reported second quarter 2023 results reflecting strong financial performance, including double-digit growth in revenue, operating earnings, and adjusted earnings per share.

Elevance Health (NYSEELV) will release second quarter 2023 financial results on July 19, 2023, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:

Elevance Health (NYSEELV) announced today that senior management is scheduled to present at the Goldman Sachs 44th Annual Global Healthcare Conference in Dana Point, California on June 13th at 10:00 a.m. Pacific Daylight Time (PDT)/1:00 p.m. Eastern Daylight Time (EDT). All interested parties are invited to listen to a live webcast of the presentation by visiting www.elevancehealth.com and selecting the “Investors” link. You may also access the link here. For those of you unable to listen to the live webcast, a replay will be available for 90 days following the presentation.

Elevance Health (NYSEELV) announced today that senior management is scheduled to present at the Bernstein 39th Annual Strategic Decisions Conference in New York City on June 1, at 8:00 a.m. Eastern Daylight Time (EDT). All interested parties are invited to listen to a live webcast of the presentation by visiting www.elevancehealth.com and selecting the “Investors” link. You may also access the webcast by clicking on the following link https://kvgo.com/bernstein-2023-39th-annual-sdc/elevance-june. For those unable to listen to the live webcast, a replay will be available for 90 days following the presentation.

Elevance Health (NYSEELV) announced today that senior management is scheduled to present at the 2023 RBC Capital Markets Global Healthcare Conference in New York City on May 17, at 8:00 a.m. Eastern Standard Time (EST). All interested parties are invited to listen to a webcast of the presentation by visiting www.elevancehealth.com and selecting the “Investors” link. Following the presentation, a webcast replay will be available for 90 days.

Elevance Health, Inc. (NYSEELV) reported first quarter 2023 results reflecting strong financial performance, including double-digit growth in revenue, operating earnings, and adjusted earnings per share.

Elevance Health (NYSEELV) will release first quarter 2023 financial results on April 19, 2023, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:

In a new report issued by Elevance Health, Inc. (NYSEELV) the company highlights its continued efforts to advance health beyond healthcare by partnering with the nation’s care providers. The Advancing Health Together: Progress Report details how by working together to contract for outcomes, collaborate for success, and connect for health, Elevance Health and its care provider partners are measurably improving health access, outcomes, and affordability.

Individuals who experience long COVID are at increased risk for a wide range of adverse cardiovascular and pulmonary conditions and mortality, according to a new study published in JAMA Health Forum. The study, led by researchers at the Elevance Health Public Policy Institute, found substantially higher mortality rates for individuals with long COVID than what had been found in previous studies.

Elevance Health, Inc. (NYSEELV) announced today that for the six-month interest period commencing on October 15, 2022, its 2.750% Senior Convertible Debentures due 2042 (the “Debentures”) will accrue contingent interest at a rate of 0.50% per annum of the average trading price of a Debenture for the ten consecutive trading days ended October 14, 2022. Contingent interest, which the Company has determined to be approximately $16.8123 per Note, will be payable on April 15, 2023 to holders of the Debentures as of the April 1, 2023 record date.

Elevance Health, Inc. (NYSEELV) reported fourth quarter and full year 2022 results reflecting strong financial performance, including double-digit growth in revenue, operating earnings, and adjusted earnings per share.

Elevance Health, Inc. (NYSEELV) and Blue Cross and Blue Shield of Louisiana announced today that the companies have entered into a definitive agreement through which Elevance Health agrees to acquire Blue Cross and Blue Shield of Louisiana (BCBSLA). BCBSLA will join Elevance Health’s affiliated Anthem Blue Cross Blue Shield family of brands.

Elevance Health (NYSEELV) will release fourth quarter 2022 financial results on January 25, 2023, at 6:00 a.m. Eastern Standard Time (“EST”). Management will review these results and its outlook during a conference call at 8:30 a.m. EST that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:

Elevance Health, Inc. (NYSEELV) announced today that 21 of its affiliated Medicaid plans are the first in the nation to earn a full three-year accreditation for health equity from the National Committee for Quality Assurance (NCQA). The accreditation demonstrates Elevance Health’s commitment to advancing health equity and prioritizing the whole health needs of entire communities of people who have been historically marginalized, economically and socially.

As digital health technology continues to advance and the healthcare industry evolves, many Americans want the ability to utilize more digital methods when it comes to managing their health, according to a study recently released by Elevance Health – formerly Anthem, Inc. For people who have used virtual primary care, the vast majority of them (94%) are satisfied with their experience, and nearly four in five (79%) say it has allowed them to take charge of their health. Survey respondents also indicated that convenience and accessibility are among the top traits that attract them to digital methods like virtual primary care.

The Board of Directors of Elevance Health (NYSEELV) announced that Deanna Strable will be joining the Board. She will serve on the Audit and Governance Committees.

Elevance Health, Inc. (NYSEELV) reported third quarter 2022 results reflecting strong financial performance, including double-digit growth in revenue, operating earnings, and adjusted earnings per share.

Elevance Health, Inc. (NYSEELV) announced today that its 2023 affiliated Medicare Advantage plans have earned an overall quality rating of 4 out of 5 Stars from the Centers for Medicare & Medicaid Services (CMS).

Elevance Health, (NYSEELV), one of the nation’s leading health companies, and Aledade, an innovative primary care physician enablement company, today announced a partnership that will help enhance the consumer experience and health outcomes for those seeking services from independent primary care practices. The partnership centers on assisting independent primary care physicians across the country transition to value-based care, which is proven to improve health outcomes and lower costs for consumers.

Inconsistent and incomplete data about health plan enrollees’ races and ethnicities makes it difficult to track and evaluate efforts to reduce health inequities, according to new research conducted by the Urban Institute, the American Benefits Council and Deloitte’s Health Equity Institute, and funded by Elevance Health.

Elevance Health, Inc. (NYSEELV) reported second quarter 2022 results reflecting strong financial performance, including double-digit growth in revenue, operating earnings, and adjusted earnings per share.

Elevance Health (NYSEELV) will release second quarter 2022 financial results on July 20, 2022, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:

President and CEO Gail K. Boudreaux celebrates Elevance Health’s official rebranding with the ringing of the opening bell at the New York Stock Exchange. Joining Boudreaux are members of the board of directors and the company’s senior leadership team. The company will now trade under the ticker symbol “ELV.”